NEWTOWN, Pa.--(BUSINESS WIRE)--Onconova Therapeutics, Inc. today announced the presentation of four scientific studies relating to its lead anticancer drug ON 01910.Na and a new class of anticancer compounds at the Annual Meeting of the American Association for Cancer Research (AACR), being held April 18-22, 2009 in Denver.
